No patterns or clusters were observed from these cases. 
 
Note: This ADCO is prepared for Decentralised procedure (DCP NL/H/2494/001-002/DC). The 
cumulative data consider from 19-Apr-2017 to DLP of this report. 
A single table of summary tabulation of serious and non-serious reactions is presented side-by-side and is 
organized by MedDRA SOC. A summary tabulation of adverse reactions for esomeprazole as extracted 
from company safety database has been appended as Appendix 20.3 (Table B). 
